Best Youtube/Dailymotion Download & Convert to MP3
Search Available :
- Home
- Anime
- Music
- Funnies Video
- Horror Movie
- Forex Guide
- Motor Sport
- Movie trailer
- Magic Trick
- Film TV
- Tech Science
- Elif Bolum
- Entertainment
- Dangdut Koplo
|
Loading...
|
 |
Adjuvant Therapy | 2023 Best of Breast Conference Channel : Total Health | Oncology |
 |
New Breast Cancer Clinical Trial: Aspirin for Node Positive HER2 Negative Breast Cancer Channel : Power Life Sciences |
 |
Genomic Assays for Chemotherapy Decisions in ER-Positive/HER2-Negative Breast Cancer Channel : Targeted Oncology |
 |
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne Channel : European Society for Medical Oncology (ESMO) |
 |
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer Channel : OncLive |
 |
Top breast cancer abstracts at ASCO 2023: NATALEE and PHERGain Channel : VJOncology |
 |
ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew Sedona Channel : Total Health | Oncology |
 |
Updates in the Treatment of Early Stage Breast Cancer Channel : Bay Area Cancer Connections |
 |
Pathology Grand Rounds April 2025 - Sponsored by PathSoc & the Jean Shanks Foundation Channel : Pathological Society GB and Ireland |
 |
Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer Channel : VJOncology |
 |
#ESMO21 Expert Video Report on HER2-positive early breast cancer Channel : European Society for Medical Oncology (ESMO) |
 |
Dr Richard De Boer discusses the TAILORx trial of OncotypeDX Channel : Breast Cancer Network Australia |
 |
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy Channel : ecancer |
 |
Comment: Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer pts Channel : ecancer |
 |
Standard of care practice in Adjuvant HR+ Breast Cancer before ASCO 2023 #oncology #ASCO2023 #cancer Channel : OncBrothers: Practice-Changing Cancer Discussions |
 |
Elacestrant shows improved PFS in patients with ER-positive/HER2-negative metastatic breast cancer Channel : ecancer |
 |
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer Channel : ecancer |
 |
Breast cancer trials of interest at ESMO 2022 Channel : VJOncology |
 |
Safety outcomes in the Phase III monarchE trial of abemaciclib + ET in HR+, HER2- breast cancer Channel : VJOncology |
 |
Breast Cancer Research at ESMO 20: Erica L. Mayer, MD, MPH Channel : Dana-Farber Cancer Institute |
|
